Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update Article

Visvanathan, Kala, Fabian, Carol J, Bantug, Elissa et al. (2019). Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update . JOURNAL OF CLINICAL ONCOLOGY, 37(33), 3152-+. 10.1200/JCO.19.01472

Open Access International Collaboration

cited authors

  • Visvanathan, Kala; Fabian, Carol J; Bantug, Elissa; Brewster, Abenaa M; Davidson, Nancy E; DeCensi, Andrea; Floyd, Justin D; Garber, Judy E; Hofstatter, Erin W; Khan, Seema A; Katapodi, Maria C; Pruthi, Sandhya; Raab, Rachal; Runowicz, Carolyn D; Somerfield, Mark R

sustainable development goals

authors

publication date

  • November 20, 2019

webpage

published in

keywords

  • AMERICAN-SOCIETY
  • BOWEL PROJECT
  • CARCINOMA IN-SITU
  • INCLUDING TAMOXIFEN
  • Life Sciences & Biomedicine
  • ONCOLOGY TECHNOLOGY-ASSESSMENT
  • Oncology
  • PHARMACOLOGICAL INTERVENTIONS
  • POSTMENOPAUSAL WOMEN
  • QUALITY-OF-LIFE
  • REPORTED SYMPTOMS
  • SURGICAL ADJUVANT BREAST
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 3152

end page

  • +

volume

  • 37

issue

  • 33